Malignant hyperthermia during ECT
- PMID: 2006702
- DOI: 10.1176/ajp.148.4.541b
Malignant hyperthermia during ECT
Similar articles
-
Caution for psychiatrists: malignant hyperthermia risks with the anesthetic agent succinylcholine (Suxamethonium) during electroconvulsive therapy.BMC Psychiatry. 2024 Jun 4;24(1):411. doi: 10.1186/s12888-024-05846-5. BMC Psychiatry. 2024. PMID: 38834964 Free PMC article.
-
Malignant hyperthermia and ECT.Am J Psychiatry. 1986 Aug;143(8):1027-9. doi: 10.1176/ajp.143.8.1027. Am J Psychiatry. 1986. PMID: 3524274 Review.
-
More on ECT and malignant hyperthermia.Am J Psychiatry. 1983 Feb;140(2):266-7. doi: 10.1176/ajp.140.2.266c. Am J Psychiatry. 1983. PMID: 6849456 No abstract available.
-
Rapacuronium: an alternative to succinylcholine for electroconvulsive therapy.Anesth Analg. 2001 May;92(5):1171-2. doi: 10.1097/00000539-200105000-00018. Anesth Analg. 2001. PMID: 11323342 No abstract available.
-
[Malignant hyperthermia].Tunis Med. 2002 Jul;80(7):395-401. Tunis Med. 2002. PMID: 12611349 Review. French.
Cited by
-
Prolonged Post-electroconvulsive Therapy Delirium: An Unusual Presentation.Cureus. 2018 Aug 28;10(8):e3221. doi: 10.7759/cureus.3221. Cureus. 2018. PMID: 30405996 Free PMC article.
-
Propofol-remifentanil combination for management of electroconvulsive therapy in a patient with neuroleptic malignant syndrome.Case Rep Med. 2012;2012:585713. doi: 10.1155/2012/585713. Epub 2012 Apr 3. Case Rep Med. 2012. PMID: 22548079 Free PMC article.
-
RECURRENT SELF-LIMITED HYPERTHERMIA FOLLOWING ELECTROCONVULSIVE THERAPY.Actas Esp Psiquiatr. 2023 Jan;51(1):41-43. Epub 2023 Jan 1. Actas Esp Psiquiatr. 2023. PMID: 36912393 Free PMC article.
-
Caution for psychiatrists: malignant hyperthermia risks with the anesthetic agent succinylcholine (Suxamethonium) during electroconvulsive therapy.BMC Psychiatry. 2024 Jun 4;24(1):411. doi: 10.1186/s12888-024-05846-5. BMC Psychiatry. 2024. PMID: 38834964 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources